Literature DB >> 28508947

Podocytes from the diagnostic and therapeutic point of view.

Janina Müller-Deile1, Mario Schiffer2.   

Abstract

The central role of podocytes in glomerular diseases makes this cell type an interesting diagnostic tool as well as a therapeutic target. In this review, we discuss the current literature on the use of podocytes and podocyte-specific markers as non-invasive diagnostic tools in different glomerulopathies. Furthermore, we highlight the direct effects of drugs currently used to treat primary glomerular diseases and describe their direct cellular effects on podocytes. A new therapeutic potential is seen in drugs targeting the podocytic actin cytoskeleton which is essential for podocyte foot process structure and function. Incubation of cultured human podocyte cell lines with sera from patients with active glomerular diseases is currently also used to identify novel circulating factors with pathophysiological relevance for the glomerular filtration barrier. In addition, treatment of detached urinary podocytes from patients with substances that restore their cytoskeleton might serve as a novel personalized tool to estimate their potential for podocyte recovery ex vivo.

Entities:  

Keywords:  Actin cytoskeleton; Podocyts; Podocyturia; Urinary podocyte mRNAs; Urinary podocyte proteins

Mesh:

Substances:

Year:  2017        PMID: 28508947     DOI: 10.1007/s00424-017-1993-z

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  90 in total

1.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Authors:  F A Harding; J G McArthur; J A Gross; D H Raulet; J P Allison
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

2.  Basic research: Podocyte progenitors and ectopic podocytes.

Authors:  Laura Lasagni; Paola Romagnani
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

Review 3.  Podocyte directed therapy of nephrotic syndrome-can we bring the inside out?

Authors:  Janina Müller-Deile; Mario Schiffer
Journal:  Pediatr Nephrol       Date:  2015-05-05       Impact factor: 3.714

4.  Drugs targeting dynamin can restore cytoskeleton and focal contact alterations of urinary podocytes derived from patients with nephrotic syndrome.

Authors:  Janina Müller-Deile; Beina Teng; Heiko Schenk; Hermann Haller; Jochen Reiser; Sanja Sever; Mario Schiffer
Journal:  Ann Transl Med       Date:  2016-11

5.  Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium.

Authors:  M W Seiler; H G Rennke; M A Venkatachalam; R S Cotran
Journal:  Lab Invest       Date:  1977-01       Impact factor: 5.662

6.  The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.

Authors:  H Trachtman; R Del Pizzo; E Valderrama; B Gauthier
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

7.  Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor.

Authors:  Federico Perosa; Elvira Favoino; Maria Antonietta Caragnano; Franco Dammacco
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

8.  Comparison of serum and urinary nephrin levels between normal pregnancies and severe preeclampsia.

Authors:  Ga Hyun Son; Ja Young Kwon; Sanghoo Lee; Jimyeong Park; Young-Jin Kim; Bohyon Yun; Jung Hwa Park
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-10-29       Impact factor: 2.435

9.  CTLA-4 ligation blocks CD28-dependent T cell activation.

Authors:  T L Walunas; C Y Bakker; J A Bluestone
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Feasibility of nephrinuria as a screening tool for the risk of pre-eclampsia: prospective observational study.

Authors:  Tianyue Zhai; Itsuko Furuta; Rina Akaishi; Kosuke Kawabata; Kentaro Chiba; Takeshi Umazume; Satoshi Ishikawa; Takahiro Yamada; Mamoru Morikawa; Hisanori Minakami
Journal:  BMJ Open       Date:  2016-08-02       Impact factor: 2.692

View more
  11 in total

1.  Mitochondrial biogenesis induced by the β2-adrenergic receptor agonist formoterol accelerates podocyte recovery from glomerular injury.

Authors:  Ehtesham Arif; Ashish K Solanki; Pankaj Srivastava; Bushra Rahman; Wayne R Fitzgibbon; Peifeng Deng; Milos N Budisavljevic; Catalin F Baicu; Michael R Zile; Judit Megyesi; Michael G Janech; Sang-Ho Kwon; Justin Collier; Rick G Schnellmann; Deepak Nihalani
Journal:  Kidney Int       Date:  2019-05-06       Impact factor: 10.612

2.  Ropivacaine with intraspinal administration alleviates preeclampsia-induced kidney injury via glycocalyx /alpha 7 nicotinic acetylcholine receptor pathway.

Authors:  Shen Sun; Yaojun Lu; Fubo Tian; Shaoqiang Huang
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Puromycin aminonucleoside-induced podocyte injury is ameliorated by the Smad3 inhibitor SIS3.

Authors:  Lina Jiang; Hong Cui; Jie Ding; Aijun Yang; Yingchao Zhang
Journal:  FEBS Open Bio       Date:  2020-07-07       Impact factor: 2.693

4.  Aberrant activation of Notch-1 signaling inhibits podocyte restoration after islet transplantation in a rat model of diabetic nephropathy.

Authors:  Yunqiang He; Mei Zhang; Ying Wu; Hemin Jiang; Hongxing Fu; Yong Cai; Ziqiang Xu; Chengyang Liu; Bicheng Chen; Tao Yang
Journal:  Cell Death Dis       Date:  2018-09-20       Impact factor: 8.469

5.  Single-cell transcriptomics reveals gene expression dynamics of human fetal kidney development.

Authors:  Mazène Hochane; Patrick R van den Berg; Xueying Fan; Noémie Bérenger-Currias; Esmée Adegeest; Monika Bialecka; Maaike Nieveen; Maarten Menschaart; Susana M Chuva de Sousa Lopes; Stefan Semrau
Journal:  PLoS Biol       Date:  2019-02-21       Impact factor: 8.029

Review 6.  CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.

Authors:  Yoong Mond Teh; Soo Kun Lim; Norhana Jusoh; Kahar Osman; Siti Aisyah Mualif
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

7.  Bioinformatics analysis reveals the roles of cytoskeleton protein transgelin in occurrence and development of proteinuria.

Authors:  Yingxue Ding; Zongli Diao; Hong Cui; Aijun Yang; Wenhu Liu; Lina Jiang
Journal:  Transl Pediatr       Date:  2021-09

8.  Podocyturia in Fabry disease: a 10-year follow-up.

Authors:  Bojan Vujkovac; Irena Srebotnik Kirbiš; Tajda Keber; Andreja Cokan Vujkovac; Martin Tretjak; Sandra Radoš Krnel
Journal:  Clin Kidney J       Date:  2021-09-16

9.  Differentiation of human iPSCs into functional podocytes.

Authors:  Caroline Rauch; Elisabeth Feifel; Georg Kern; Cormac Murphy; Florian Meier; Walther Parson; Mario Beilmann; Paul Jennings; Gerhard Gstraunthaler; Anja Wilmes
Journal:  PLoS One       Date:  2018-09-17       Impact factor: 3.240

10.  Bisphenol A impaired cell adhesion by altering the expression of adhesion and cytoskeleton proteins on human podocytes.

Authors:  Rafael Moreno-Gómez-Toledano; María I Arenas; Clara González-Martínez; Nuria Olea-Herrero; Paula Reventún; Michele Di Nunzio; Sandra Sánchez-Esteban; Eduardo Arilla-Ferreiro; Marta Saura; Ricardo J Bosch
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.